Search

Author/Creator Light, David E.

1. Characteristics of Real‐World Metastatic Non‐Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval. (9th January 2018)

Authors:
Khozin, Sean; Abernethy, Amy P.; Nussbaum, Nathan C.; Zhi, Jizu; Curtis, Melissa D.; Tucker, Melisa; Lee, Shannon E.; Light, David E.; Gossai, Anala; Sorg, Rachael A.; Torres, Aracelis Z.; Patel, Payal; Blumenthal, Gideon Michael; Pazdur, Richard
Journal:
Oncologist
Issue:
Volume 23:Number 3(2018)
Page Start:
328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Real‐World Outcomes of Patients with Metastatic Non‐Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval. (27th December 2018)

Authors:
Khozin, Sean; Carson, Kenneth R.; Zhi, Jizu; Tucker, Melisa; Lee, Shannon E.; Light, David E.; Curtis, Melissa D.; Bralic, Marta; Kaganman, Irene; Gossai, Anala; Hofmeister, Philip; Torres, Aracelis Z.; Miksad, Rebecca A.; Blumenthal, Gideon Michael; Pazdur, Richard; Abernethy, Amy P.
Journal:
Oncologist
Issue:
Volume 24:Number 5(2019)
Page Start:
648
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search